French Software Stock News

ENXTPA:ORA
ENXTPA:ORATelecom

Orange (ENXTPA:ORA) Returned To Profit And Expanded Data Centres, Is It Still 14% Below Fair Value?

Why Orange stock is back in focus after earnings and data centre deal Orange (ENXTPA:ORA) has moved into the spotlight after half year 2026 results showed a swing from loss to profit, alongside a new data centre joint venture aimed at serving AI and cloud demand in France. See our latest analysis for Orange. Orange’s recent earnings swing and the planned data centre joint venture arrive after a mixed share price run, with short term momentum still patchy but longer term total shareholder...
ENXTPA:BIM
ENXTPA:BIMMedical Equipment

Is bioMérieux’s Margin-First Shift After H1 2026 Results Altering The Investment Case For bioMérieux (ENXTPA:BIM)?

In late July 2026, bioMérieux S.A. reported half-year results showing sales of €1,964.6 million versus €2,043.8 million a year earlier, while net income rose to €226.1 million from €161 million and basic earnings per share from continuing operations increased to €1.92 from €1.36. The combination of lower sales yet higher earnings suggests meaningful efficiency gains or cost discipline that materially improved profitability for the period. We’ll now examine how this profitability improvement,...
ENXTPA:SAF
ENXTPA:SAFAerospace & Defense

3 Aerospace And Defense Stocks Retail Investors Are Watching As Funding Pressure Eases

Central banks are easing away from aggressive tightening as inflation readings cool in several regions, which takes some pressure off funding costs for capital heavy sectors such as aerospace and defense. For investors, that creates a window where demand for security and critical infrastructure still matters, yet money is not getting steadily more expensive. This article highlights three Aerospace And Defense screener stocks that stand out on current fundamentals. The three aerospace and...
ENXTPA:AI
ENXTPA:AIChemicals

How Investors May Respond To L'Air Liquide (ENXTPA:AI) Modest H1 2026 Gains And New U.S. Chip Investment

Air Liquide has released its half-year 2026 results, reporting modest year-on-year increases in sales to €13,827.9 million and net income to €1,822.6 million, alongside slightly higher earnings per share. The company also committed over US$150 million to a new ultra-pure industrial gas facility in Idaho to support advanced semiconductor memory production, underlining its deepening role in supplying critical materials for AI-related chip manufacturing and reshoring efforts in the U.S. We’ll...
ENXTPA:CAP
ENXTPA:CAPIT

Capgemini (ENXTPA:CAP) Could Be 24% Below Fair Value As Half Year Earnings Land

Capgemini earnings update and why the stock is in focus Capgemini (ENXTPA:CAP) has drawn fresh attention after reporting half year 2026 results. Sales reached €12,082 million compared with €11,107 million a year earlier, while net income and earnings per share declined over the same period. See our latest analysis for Capgemini. The earnings release has arrived at a time when Capgemini’s share price has shown a 17.46% 1 month share price return, yet the stock remains down 22.56% on a year to...
ENXTPA:RI
ENXTPA:RIBeverage

Diageo Stock News Puts Constellation Brands Pernod Ricard And AB InBev In Focus

Diageo’s new US$1b cost cutting plan and the share price surge that followed has put the entire global spirits sector under a sharper spotlight. When a heavyweight publicly chases efficiency, it can pressure competitors’ margins, pricing and brand spending. That can create both blind spots and opportunities for investors. This article examines how that news may affect three stocks closely exposed to the same forces, and why that may be relevant for your portfolio decisions now. Constellation...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Could Sanofi’s (ENXTPA:SAN) Expanded Infant Vaccine Approval Reinforce Its Vaccines-Led Investment Story?

In late July 2026, the European Commission approved Sanofi’s MenQuadfi meningococcal vaccine for use in EU infants from six weeks of age, extending coverage against serogroups A, C, W, and Y and aligning dosing with routine pediatric schedules. This broadened indication gives Sanofi an earlier entry point into infant immunization programs, potentially deepening its vaccines footprint in a high‑need, high‑risk population. Next, we’ll examine how gaining infant approval for MenQuadfi across...
ENXTPA:DG
ENXTPA:DGConstruction

Why Vinci (ENXTPA:DG) Is Up 6.7% After Strong H1 2026 Results And Higher Dividend

Vinci SA recently reported past half-year 2026 results showing sales of €36,040 million and net income of €2,078 million, alongside higher earnings per share versus a year earlier. The company also approved a higher interim dividend of €1.10 per share for 2026 and confirmed guidance for further growth in revenue, operating earnings and net income, underlining management’s confidence in its current trajectory. Next, we’ll examine how Vinci’s stronger first-half profitability and increased...
ENXTPA:ERA
ENXTPA:ERAMetals and Mining

3 European Stocks That May Be Undervalued In August 2026

In recent weeks, the European markets have shown resilience, with the pan-European STOXX Europe 600 Index reaching new highs driven by strong corporate earnings and a recovery in sentiment toward AI-related stocks. As investors navigate these evolving conditions, identifying potentially undervalued stocks can be a strategic approach to capitalize on market opportunities.
ENXTPA:SAF
ENXTPA:SAFAerospace & Defense

Safran (ENXTPA:SAF) Following Raised 2026 Guidance, Is Fair Value Still In Reach?

Why Safran stock is in focus after new guidance and half year results Safran (ENXTPA:SAF) drew fresh attention after its board met on 27 July to review half year 2026 figures and the company raised full year revenue growth guidance despite a drop in net income. The company now expects 2026 revenue growth in the mid teens, with management indicating a target above €36b. This update followed half year 2026 sales of €17,245m and revenue of €17,458m. See our latest analysis for Safran. Safran’s...
ENXTPA:RF
ENXTPA:RFDiversified Financial

Eurazeo (ENXTPA:RF) Stock Rich Valuation Meets Losses And Thin Dividend Cover

Eurazeo stock barely flinched into these H1 2026 results, with the shares at €50.65 after a solid run over the past month. Yet the earnings story is less about the share price and more about the balance sheet. The group still sits on a rich price to sales multiple of 9.3x while reporting losses on a trailing twelve month basis. The real headline is the tension between a high valuation, ongoing losses and a 6.34% dividend yield that is poorly covered by earnings and free cash flow. Like the...
ENXTPA:CRAV
ENXTPA:CRAVBanks

Caisse Régionale De Crédit Agricole Atlantique Vendée (ENXTPA:CRAV) Stock Price Meets Funding Doubts

The market has spent the past three months marking Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée down, with the stock now about 12% lower even after closing at €138. Yet the latest half year numbers tell a more complicated story. Earnings over the last 12 months reached €105.3 million and the net profit margin sits at 23.1%. The stock trades on a P/E of 9.7x, which leaves you weighing a cheaper valuation against a bank that still carries 65% of its liabilities in higher risk...
ENXTPA:AKE
ENXTPA:AKEChemicals

Arkema (ENXTPA:AKE) Following Softer Half Year Earnings Still Looks Near Fair Value

Why Arkema’s Latest Half Year Earnings Matter For Investors Arkema (ENXTPA:AKE) reported half year 2026 results with sales of €4,609.6 million and net income of €92.9 million, both lower than a year earlier. Earnings per share also declined over the period. See our latest analysis for Arkema. Arkema’s latest half year earnings came alongside a 1 month share price return of 8.04% and a year to date share price return of 16.81%, although the 3 year total shareholder return declined 26.02%...
ENXTPA:AC
ENXTPA:ACHospitality

August 2026 European Stocks Estimated Below Fair Value

The European stock market has recently experienced a positive momentum, with the STOXX Europe 600 Index reaching new highs driven by strong corporate earnings and renewed interest in AI-related stocks. Amidst this backdrop, identifying undervalued stocks becomes crucial as investors seek opportunities that are priced below their intrinsic value, offering potential for future growth within a recovering economy.
ENXTPA:MRN
ENXTPA:MRNElectrical

3 European Stocks Estimated To Be Trading At Discounts Of Up To 40.6%

The European market has recently seen a positive uptick, with the STOXX Europe 600 Index reaching new highs driven by robust corporate earnings and renewed optimism in AI-related stocks. As investors navigate this landscape, identifying undervalued stocks can offer potential opportunities for those looking to capitalize on discrepancies between a company's intrinsic value and its current market price.
ENXTPA:ERA
ENXTPA:ERAMetals and Mining

Is ERAMET (ENXTPA:ERA) Undervalued On Mixed Production Results And Confirmed Guidance?

ERAMET (ENXTPA:ERA) has drawn fresh investor attention after reporting mixed second quarter and first half 2026 production figures, confirming full year guidance and outlining progress on manganese projects in Gabon. See our latest analysis for ERAMET. ERAMET's recent production update and confirmed guidance come against a weak backdrop for the stock, with the share price down 26.29% over 90 days and the 1 year total shareholder return declining 9.11%. However, short term share price momentum...
ENXTPA:ELIS
ENXTPA:ELISCommercial Services

How Half-Year Sales and EPS Gains At Elis (ENXTPA:ELIS) Has Changed Its Investment Story

Elis SA recently reported its half-year results for the period ended June 30, 2026, with sales of €2,457.1 million and net income of €163.6 million, both higher than a year earlier, and basic earnings per share from continuing operations rising to €0.73. The concurrent increase in sales, net income and both basic and diluted earnings per share highlights operational efficiency gains that build on Elis’s recurring-revenue model. We’ll now examine how this half-year improvement in sales and...
ENXTPA:NRO
ENXTPA:NROIT

Top European Dividend Stocks For August 2026

As European markets continue to show resilience with the STOXX Europe 600 Index reaching new highs, driven by strong corporate earnings and renewed interest in AI-related stocks, investors are increasingly looking toward dividend stocks as a stable source of income amidst economic growth surprises and inflationary pressures. In this environment, selecting robust dividend stocks can provide both steady income and potential capital appreciation, making them an attractive option for those...
ENXTPA:AI
ENXTPA:AIChemicals

L'Air Liquide (ENXTPA:AI) Expands In Idaho Following Half Year Results, Is It 12% Undervalued?

L'Air Liquide (ENXTPA:AI) is back in focus after a board meeting to review half year financials and a fresh earnings release, along with a planned gas facility investment of over US$150 million in Idaho. See our latest analysis for L'Air Liquide. The latest share price of €170.72 follows a 1-month share price return that declined 5.31% and a 7-day return that fell 3.29%. However, the year-to-date share price return is up 18.11% and the 5-year total shareholder return is 69.49%, suggesting...
ENXTPA:TEP
ENXTPA:TEPProfessional Services

Teleperformance (ENXTPA:TEP) Is Up 22.5% After Softer H1 2026 Earnings And Cautious Outlook – Has The Bull Case Changed?

Teleperformance SE recently reported half-year 2026 results showing sales of €4,883 million and net income of €216 million, both below the prior year, alongside lower basic and diluted earnings per share from continuing operations. Alongside these softer figures, the company issued a cautious full-year 2026 outlook, targeting flat to low-single-digit like-for-like revenue growth, which may prompt investors to reassess its earnings resilience and efficiency efforts. Next, we will examine how...